OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
OTC: GHVNF 21.76%
Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NASDAQ: ACXIF 31.15%
NASDAQ: KORE 31.15%
NASDAQ: GHVNF 31.15%
NASDAQ: PSKY 31.15%
